CHEM2052 Tutorial Example4
From Proteopedia
| Line 2: | Line 2: | ||
<scene name='59/596437/Renin_catalytic_residues/1'>Renin Catalytic Residues</scene> | <scene name='59/596437/Renin_catalytic_residues/1'>Renin Catalytic Residues</scene> | ||
| - | This is a default text for your page '''CHEM2052 Tutorial Example4'''. Click above on '''edit this page''' to modify. Be careful with the < and > signs. | ||
| - | You may include any references to papers as in: the use of JSmol in Proteopedia <ref>DOI 10.1002/ijch.201300024</ref> or to the article describing Jmol <ref>PMID:21638687</ref> to the rescue. | ||
| - | == | + | |
| + | == Background == | ||
In later lecture we will look at an enzyme called Renin (also known as angiotensinase). This enzyme is involved in a biological pathway leading to elevation of blood pressure, which can be beneficial in many ways. However if this process has become overactive, hypertension (high blood pressure) can result. Hypertension leads to cardiovascular disease which is the leading cause of death globally. The World Health Organisation states "An estimated 17.3 million people died from cardiovascular disease in 2008, representing 30% of all global deaths" see the following web page if you want to know more: [http://www.who.int/mediacentre/factsheets/fs317/en/]. | In later lecture we will look at an enzyme called Renin (also known as angiotensinase). This enzyme is involved in a biological pathway leading to elevation of blood pressure, which can be beneficial in many ways. However if this process has become overactive, hypertension (high blood pressure) can result. Hypertension leads to cardiovascular disease which is the leading cause of death globally. The World Health Organisation states "An estimated 17.3 million people died from cardiovascular disease in 2008, representing 30% of all global deaths" see the following web page if you want to know more: [http://www.who.int/mediacentre/factsheets/fs317/en/]. | ||
| Line 13: | Line 12: | ||
| - | == | + | == Active Site and Mechanism == |
| - | == | + | == Inhibitors == |
== Structural highlights == | == Structural highlights == | ||
Revision as of 12:56, 7 August 2014
Contents |
CHEM2052_Tutorial_Example4
Background
In later lecture we will look at an enzyme called Renin (also known as angiotensinase). This enzyme is involved in a biological pathway leading to elevation of blood pressure, which can be beneficial in many ways. However if this process has become overactive, hypertension (high blood pressure) can result. Hypertension leads to cardiovascular disease which is the leading cause of death globally. The World Health Organisation states "An estimated 17.3 million people died from cardiovascular disease in 2008, representing 30% of all global deaths" see the following web page if you want to know more: [1].
Since the 1970s Renin Wikipedia Site scientists have been trying to modulate the action of renin by blocking the active site of the enzyme and preventing its function, hence lowering blood pressure. Aliskerin is the only renin inhibitor in clinical use today. However there is still interest in developing new, improved inhibitors. This question looks at a renin inhibitor identified through research at Pfizer.
Active Site and Mechanism
Inhibitors
Structural highlights
This is a sample scene created with SAT to by Group, and another to make of the protein. You can make your own scenes on SAT starting from scratch or loading and editing one of these sample scenes.
</StructureSection>
